Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Arlen Myron | 0001495539 | Feb-13-2013 | 10 percent owner |
Arlen Philip | 0001495540 | Feb-13-2013 | director, officer: President and CEO |
Martin Albine | 0001513046 | Feb-09-2011 | officer: CHIEF OPERATING OFFICER |
HOLLADAY J DOUGLAS | 0001224315 | Jun-29-2010 | director |
SHRIVER TIMOTHY P | 0001244217 | Jun-29-2010 | director |
KROMINGA LYNN | 0001376958 | Jun-29-2010 | director |
Gordon Peter | 0001495541 | Jun-29-2010 | director, 10 percent owner, officer: CFO and Secretary |
Feldman James | 0001495542 | Jun-29-2010 | director |
Greene Dennis | 0001495543 | Jun-29-2010 | director |
Gause Barry | 0001495544 | Jun-29-2010 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Neogenix Oncology Inc
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
REVOKED | Document | Acc-no: 9999999997-20-000012 (34 Act) Size: KB | Aug-26-2019 | 20500955 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001144204-13-008317 ( Act) Size: 0 KB |
Feb-13-2013 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001144204-13-008299 ( Act) Size: 0 KB |
Feb-13-2013 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001144204-13-008298 ( Act) Size: 0 KB |
Feb-13-2013 | |
8-K | Document | Current report filing Acc-no: 0001144204-12-053545 (34 Act) Size: KB |
Sep-28-2012 | 121115951 |
8-K | Document | Current report filing Acc-no: 0001144204-12-050141 (34 Act) Size: KB |
Sep-07-2012 | 121079791 |
8-K | Document | Current report filing Acc-no: 0001144204-12-041175 (34 Act) Size: KB |
Jul-26-2012 | 12988077 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001144204-12-039179 (34 Act) Size: KB |
Jul-12-2012 | 12959369 |
8-K | Document | Current report filing Acc-no: 0001144204-12-038358 (34 Act) Size: KB |
Jul-06-2012 | 12949883 |
8-K | Document | Current report filing Acc-no: 0001144204-12-038103 (34 Act) Size: KB |
Jul-03-2012 | 12945623 |
NTN 10Q | Document | Acc-no: 0001144204-12-033295 (34 Act) Size: KB | Jun-05-2012 | 12889028 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-12-023245 (34 Act) Size: KB |
Apr-23-2012 | 12774132 |
NT 10-K | Document | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001144204-12-018597 (34 Act) Size: KB |
Mar-30-2012 | 12727978 |
8-K | Document | Current report filing Acc-no: 0001144204-12-013197 (34 Act) Size: KB |
Mar-06-2012 | 12669579 |
8-K | Document | Current report filing Acc-no: 0001144204-12-005969 (34 Act) Size: KB |
Feb-06-2012 | 12572818 |
8-K/A | Document | Amendment to Current report filing Acc-no: 0001144204-12-001996 (34 Act) Size: KB |
Jan-12-2012 | 12523570 |
8-K | Document | Current report filing Acc-no: 0001144204-12-001993 (34 Act) Size: KB |
Jan-12-2012 | 12523563 |
NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001144204-11-065144 (34 Act) Size: KB |
Nov-15-2011 | 111207700 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-11-046926 (34 Act) Size: KB |
Aug-15-2011 | 111035057 |
8-K/A | Document | Amendment to Current report filing Acc-no: 0001144204-11-038228 (34 Act) Size: KB |
Jun-29-2011 | 11939452 |
Recent 20 filings. View all Neogenix Oncology Inc filings
young lad who new his job ansered questions and new what was best for me.
Huge help thank you for your help .. y'all make it so much easier
It's being easier working on the website. And I recommend, it's a great website
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by